UMRX - Unum Therapeutics Inc.
Close
2.35
0.010 0.426%
Share volume: 0
Last Updated: Mon 05 Oct 2020 10:00:00 PM CEST
Biotechnology:
-0.86%
PREVIOUS CLOSE
CHG
CHG%
$2.34
0.01
0.43%
Summary score
28%
Profitability
37%
Dept financing
13%
Liquidity
15%
Performance
25%
Sector
Health Technology
Industry
Biotechnology
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-22.86%
Return on assets
-13.62%
Return on sales
0%
Return on invested capital
141.55%
Total debt ratio
39.08%
Debt ratio change over timeo
-0.59%
Current Ratio
3.08%
Quick Ratio
0%
Cash Position Ratio
2.29%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-24.14%
Return on assets
-13.89%
Return on sales
0%
Return on invested capital
268.28%
Total debt ratio
39.58%
Debt ratio change over timeo
-0.87%
Current Ratio
2.82%
Quick Ratio
0%
Cash Position Ratio
2.62%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-38.42%
Return on assets
-23.52%
Return on sales
0%
Return on invested capital
635.68%
Total debt ratio
38.04%
Debt ratio change over time
-0.91%
Current Ratio
2.9%
Quick Ratio
0%
Cash Position Ratio
2.58%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-121%
Return on assets
-112.95%
Return on sales
0%
Return on invested capital
-87.96%
Total debt ratio
-58.99%
Debt ratio change over time
-0.59%
Current Ratio
2.28%
Quick Ratio
0%
Cash Position Ratio
1.17%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | UMRX | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | -22.86% | -38.69% | -11.55% | -12.25% |
| Return on assets | -13.62% | -18.71% | -9.1% | -9.49% |
| Return on sales | 0% | -4785.64% | 0% | -349.39% |
| Return on invested capital | 141.55% | 328.34% | -54.81% | -117.39% |
| Profitability | 36% | 25% | 50% | 0% |
| Total debt ratio | 39.08% | 115.92% | 25.21% | 26.21% |
| Debt ratio change over time | -0.59% | -0.17% | -1.1% | -1.45% |
| Dept financing | 8% | 50% | 5% | 6% |
| Current Ratio | 2.82% | 9.16% | 6.1% | 4.67% |
| Quick Ratio | 0% | 12.58% | 0% | 4.35% |
| Cash Position Ratio | 2.62% | 8.72% | 2.86% | 2.07% |
| Liquididy | 16% | 55% | 25% | 58% |
| Short-term ratios | UMRX | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | -24.14% | -121.38% | -14.72% | -19.25% |
| Return on assets | -13.89% | -13.34% | -11.86% | -9.76% |
| Return on sales | 0% | -264.08% | 0% | -305.87% |
| Return on invested capital | 268.28% | 262.79% | 517.6% | -49.24% |
| Profitability | 38% | 13% | 50% | 25% |
| Total debt ratio | 39.58% | 66.94% | 26.58% | 50.82% |
| Debt ratio change over time | -0.87% | -0.82% | -1.16% | -2.24% |
| Dept financing | 15% | 50% | 10% | 19% |
| Current Ratio | 2.82% | 9.16% | 6.1% | 4.67% |
| Quick Ratio | 0% | 12.58% | 0% | 4.35% |
| Cash Position Ratio | 2.62% | 8.72% | 2.86% | 2.07% |
| Liquididy | 15% | 75% | 25% | 27% |